Cold” tumors are resistant to common immunotherapies. Stanford Medicine researchers have uncovered a master regulator that ...

Removing EPO signalling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...

Anemia reduces oxygen delivery to the retina, and iron deficiency further exacerbates hypoxia by inhibiting the prolyl hydroxylase domain, which normally activates hypoxia-inducible factor 1-alpha ...

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Anemia may be caused by cancer spreading to the bone marrow, the release of various cytokines, and tumor hypoxia. Several different cytokines are involved in inflammatory processes in the body ...

A replay of the webcast of the R&D investor event is available on the “Events” page in the “Investor Relations & Media” section of the Company’s website at ...

Its product portfolio includes Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, which is in Phase III development for the treatment of anemia due to chronic kidney disease ...

Anemia reduces oxygen delivery to the retina, and iron deficiency further exacerbates hypoxia by inhibiting the prolyl hydroxylase domain, which normally activates hypoxia-inducible factor 1-alpha ...